Staging consistency of ultrasonography and pathology in rare-type cervical cancer
| USG | Pathology | |||||||||
| Tis | T1b1 | T1b2 | T2a1 | T2a2 | T2b | T3a | T3b | T4 | Total | |
| Tis | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| T1b1 | 0 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 |
| T1b2 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| T2a1 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 2 |
| T2a2 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 2 |
| T2b | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
| T3a | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| T3b | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| T4 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 2 |
| Total | 0 | 11 | 3 | 3 | 2 | 1 | 0 | 0 | 1 | 21 |
Weighted kappa=0.87(95% CI 0.65 to 1.00). For the convenience of statistics, T2a2N1 was marked as T2a2; T2bN2 was marked as T2b; T3aN1 was marked as T3a; T3bN1 was marked as T3b.